DESOXIMETASONE (desoximetasone) by Ichnos Glenmark Innovation is corticosteroid hormone receptor agonists [moa]. Approved for plaque psoriasis in patients 18 years of age, older (), older and 1 more indications. First approved in 2013.
Drug data last refreshed 20h ago
Corticosteroid Hormone Receptor Agonists
Corticosteroid
Worked on DESOXIMETASONE at Ichnos Glenmark Innovation? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.